These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Half-strength atenolol-chlorthalidone combination (tenoretic mite) in the treatment of elderly hypertensive patients. Fogari R, Zoppi A. Int J Clin Pharmacol Ther Toxicol; 1984 Jul; 22(7):386-93. PubMed ID: 6469428 [Abstract] [Full Text] [Related]
3. Assessment of a fixed-dosage combination of atenolol and chlorthalidone (Tenoretic) in hypertensive Nigerians. Salako LA, Falase AO, Aderounmu AF, Walker O. Afr J Med Med Sci; 1990 Mar; 19(1):57-61. PubMed ID: 2109522 [Abstract] [Full Text] [Related]
8. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension. Levine B. Curr Med Res Opin; 2001 Mar; 17(1):8-17. PubMed ID: 11464450 [Abstract] [Full Text] [Related]
11. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs. Adigun AQ, Ishola DA, Akintomide AO, Ajayi AA. J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973 [Abstract] [Full Text] [Related]
16. Valsartan alone and as part of combination therapy in general practice in Brazil. Madi JC, Oigman W, Franco R, Armaganijan D, Brazilian Multicenter Evaluation. Int J Clin Pract; 2001 Oct; 55(8):520-3. PubMed ID: 11695071 [Abstract] [Full Text] [Related]
17. Clinical effectiveness of low-dose chlorthalidone (6.25 mg) + atenolol combination in stage I hypertensive patients: a multicenter, randomized, controlled study. Pareek A, Karnik N, Salagre SB, Zawar SD, Joglekar VK, Chandurkar N, Naik GS. Curr Med Res Opin; 2008 Jun; 24(6):1771-9. PubMed ID: 18479589 [Abstract] [Full Text] [Related]